Literature DB >> 8104888

Induction of aggregation of Raji human B-lymphoblastic cells by vasoactive intestinal peptide.

A Robichon1, S P Sreedharan, J Yang, R S Shames, E C Gronroos, P P Cheng, E J Goetzl.   

Abstract

Subsets of neurons in the thymic cortex, Peyer's patches and lymphoid tissues of the respiratory system deliver vasoactive intestinal peptide (VIP) at nanomolar concentrations. The possible effects of VIP on B-cell adhesiveness in these tissues were examined in studies of the homotypic aggregation (HA) of human B-lymphoblastoid cells of the Raji line, which express a mean of 27,950 VIP receptors/cell with a mean Kd of 0.8 nM. Mean HA, assessed microscopically, attained a maximum of 54% after 8 hr with 0.1 microgram/ml of phorbol 12-myristate 13-acetate (PMA) (P < 0.01) and 31% after 24 hr with 10(-8) M VIP (P < 0.05), as contrasted with 13% and 20% at the respective times in medium alone, and both stimuli also increased the mean size of aggregates. The presence of the phosphodiesterase inhibitor Ro 20-1724 permitted 10(-9) M VIP, which had no effect alone, to raise the mean cyclic AMP content of Raji cells by more than 10-fold and concurrently to elevate mean HA from 55% in medium alone at 48 hr to 70% and from 55% at 72 hr to 68% (P < 0.05 for both). Monoclonal antibodies to lymphocyte function-associated (LFA-1) adhesive protein and to intercellular adherence molecule-1 (ICAM-1) suppressed significantly the HA of Raji cells induced by VIP and PMA. The effects of VIP on compartmental immunity in the lungs and intestines thus may be mediated in part by increases in lymphocyte adhesiveness, which could contribute to the regional accumulation of specifically immunocompetent cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104888      PMCID: PMC1421926     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).

Authors:  J V PULVERTAFT
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

2.  Stimulation of B lymphocytes through surface Ig receptors induces LFA-1 and ICAM-1-dependent adhesion.

Authors:  L H Dang; K L Rock
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

3.  Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.

Authors:  C A Ottaway
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

4.  Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.

Authors:  A De Lean; A A Hancock; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

5.  Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones.

Authors:  A F Kavanaugh; E Lightfoot; P E Lipsky; N Oppenheimer-Marks
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

6.  High-affinity receptors for vasoactive intestinal peptide on human myeloma cells.

Authors:  R J Finch; S P Sreedharan; E J Goetzl
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

7.  Vasoactive intestinal peptide-containing nerves in Peyer's patches.

Authors:  C A Ottaway; D L Lewis; S L Asa
Journal:  Brain Behav Immun       Date:  1987-06       Impact factor: 7.217

8.  The SKW 6.4 line of human B lymphocytes specifically binds and responds to vasoactive intestinal peptide.

Authors:  P P Cheng; S P Sreedharan; J L Kishiyama; E J Goetzl
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

9.  Activation of LFA-1 through a Ca2(+)-dependent epitope stimulates lymphocyte adhesion.

Authors:  Y van Kooyk; P Weder; F Hogervorst; A J Verhoeven; G van Seventer; A A te Velde; J Borst; G D Keizer; C G Figdor
Journal:  J Cell Biol       Date:  1991-01       Impact factor: 10.539

10.  In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells.

Authors:  C A Ottaway
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  3 in total

1.  Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.

Authors:  Kazushi Tanimoto; Yoshihiro Yakushijin; Hiroshi Fujiwara; Masaki Otsuka; Koichi Ohshima; Atsuro Sugita; Akira Sakai; Takaaki Hato; Hitoshi Hasegawa; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2009-04-11       Impact factor: 2.490

2.  The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol ester.

Authors:  W Kang; O Nielsen; C Fenger; J Madsen; S Hansen; I Tornoe; P Eggleton; K B M Reid; U Holmskov
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

3.  Synergistic anti-tumor therapy by a comb-like multifunctional antibody nanoarray with exceptionally potent activity.

Authors:  Huafei Li; Yun Sun; Di Chen; He Zhao; Mengxin Zhao; Xiandi Zhu; Changhong Ke; Ge Zhang; Cheng Jiang; Li Zhang; Fulei Zhang; Huafeng Wei; Wei Li
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.